The effect of somatostatin analogues on Ki-67 levels in GH-secreting adenomas.

CONCLUSION: We concluded that SSA treatment appears to decrease Ki-67 proliferation index independent of tumor features, SSA type, dose and treatment duration. This result suggests that SSA treatment may decrease cellular proliferation, supporting the previous studies. PMID: 30731342 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30731342?dopt=Abstract

Source: Growth Hormone and IGF Research - January 30, 2019 Category: Endocrinology Authors: Selek A, Cetinarslan B, Canturk Z, Tarkun I, Hanazay Y, Vural C, Anik I, Ceylan S Tags: Growth Horm IGF Res Source Type: research